Active Biotech AB (publ) (NASDAQ OMX Stockholm) has carried out a private placement of new shares of SEK 375 million directed towards international institutional investors and qualified investors in Sweden.
Vinge acted for Active Biotech. Vinge’s team consisted of Erik Sjöman and Christian Lindhé.